Flood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia

被引:0
|
作者
Cerhan, JR
Wallace, RB
Dick, F
Kemp, J
Parker, AS
Zheng, W
Sellers, TA
Folsom, AR
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[4] Univ S Carolina, Sch Publ Hlth, S Carolina Canc Ctr, Columbia, SC 29203 USA
[5] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic blood transfusion has been suggested as a risk factor for non-Hodgkin's lymphoma (NHL), possibly specific to certain NHL subtypes, or chronic lymphocytic leukemia (CLL). Self-reported transfusion history and risk of NHL subtypes and CLL were examined in a cohort of 37,934 older Iowa women, using data from a questionnaire mailed in 1986. Through 1997, 229 cases of NHL and 57 cases of CLL in the cohort were identified through linkage to the Iowa Surveillance, Epidemiology and End Results Cancer Registry. Women who reported ever receiving a blood transfusion were at increased risk for all NHLs [age adjusted relative risk (RR), 1.6; 95% confidence interval (CI), 1.2-2.1). On the basis of the Working Formulation classification, blood transfusion was positively associated with low-grade NHL (RR, 2.7; 95% CI, 1.7-4.5) but not with intermediate-grade NHL (RR, 1.1; 95% CI, 0.7-1.6); there were only 8 cases of high-grade NHL. Blood transfusion was positively associated with follicular (RR, 2.8; 95% CI, 1.6-5.1) and small lymphocytic (RR, 3.4; 95% CI, 1.5-7.9) NHL subtypes but not with diffuse NHL (RR, 1.0; 95% CI, 0.7-1.5). There was also a positive association with CLL (RR, 1.7; 95% CI, 1.0-3.0). Finally, transfusion was associated with nodal (RR, 1.8; 95% CI, 1.3-2.5) but not extranodal (RR, 1.2; 95% CI, 0.7-2.1) NHL. Further adjustment for marital status, farm residence, diabetes, alcohol use, smoking, and red meat and fruit consumption did not alter these associations. In conclusion, prior blood transfusion was associated with NHL and CLL, and the strongest associations were seen for low-grade NHL, particularly follicular and small lymphocytic NHL.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [1] Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Zheng, TZ
    Blair, A
    Zhang, YW
    Weisenburger, DD
    Zahm, SH
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 44 (05) : 469 - 474
  • [2] Bendamustine in chronic lymphocytic leukemia and non-Hodgkin's lymphoma
    Ujjani, Chaitra
    Cheson, Bruce D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (09) : 1353 - 1365
  • [3] Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma
    Chang, Timothy W.
    Weaver, Amy L.
    Shanafelt, Tait D.
    Habermann, Thomas M.
    Wriston, Cooper C.
    Cerhan, James R.
    Call, Timothy G.
    Brewer, Jerry D.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (11) : 1125 - 1129
  • [4] Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Cerhan, JR
    Vachon, CM
    Habermann, TM
    Ansell, SM
    Witzig, TE
    Kurtin, PJ
    Janney, CA
    Zheng, W
    Potter, JD
    Sellers, TA
    Folsom, AR
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1466 - 1471
  • [5] Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Elefante, Anjana
    Czuczman, Myron S.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (09) : 713 - 723
  • [6] Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Risto S. Cvetković
    Caroline M. Perry
    BioDrugs, 2006, 20 : 253 - 257
  • [7] Spotlight on rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Cvetkovic, Risto S.
    Perry, Caroline M.
    BIODRUGS, 2006, 20 (04) : 253 - 257
  • [8] Role of allotransplantation for non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Dreger, P.
    ANNALS OF ONCOLOGY, 2011, 22 : 36 - 39
  • [9] Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma
    Famenini, Shannon
    Martires, Kathryn J.
    Zhou, Hui
    Xavier, Marin F.
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (01) : 78 - 84
  • [10] Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan, JR
    Vachon, CM
    Habermann, TM
    Ansell, SM
    Janney, CA
    Zheng, W
    Sellers, TA
    Potter, JD
    Folsom, AR
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S121 - S121